(Q43803504)

27 November 2017

Biphasic dose-related effects of morphine on dopamine release (English)

1 reference

27 November 2017

Maisonneuve IM

1

1 reference

PubMed ID

11714590

27 November 2017

Warner LM

series ordinal

2

1 reference

PubMed ID

11714590

27 November 2017

Glick SD

series ordinal

3

1 reference

27 November 2017

1 December 2001

1 reference

Drug and Alcohol Dependence

27 November 2017

1 reference

27 November 2017

65

1 reference

27 November 2017

1

1 reference

27 November 2017

55-63

1 reference

Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

The neurosteroid pregnenolone sulphate increases dopamine release and the dopaminergic response to morphine in the rat nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Intracranial self-administration of morphine into the ventral tegmental area in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Lack of an effect of 6-hydroxydopamine lesions of the nucleus accumbens on intravenous morphine self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Effect of nucleus accumbens dopamine depletion on motivational aspects involved in initiation of cocaine and heroin self-administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Effects of cocaine and morphine in rats from two psychogenetically selected lines: a behavioral and brain dialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

(±)-18-Methoxycoronaridine: A Novel Iboga Alkaloid Congener Having Potential Anti-Addictive Efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Morphine-induced activation of A10 dopamine neurons in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Control of glutamate release by calcium channels and kappa-opioid receptors in rodent and primate striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Opioids excite dopamine neurons by hyperpolarization of local interneurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Handling and/or saline injections alter basal and morphine-evoked changes in dopamine metabolites in the striatum and nucleus accumbens of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Absence of opiate rewarding effects in mice lacking dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Update on dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Cloning and pharmacological characterization of a rat kappa opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Dopamine D3 receptor antisense influences dopamine synthesis in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Involvement of opioid mu1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Strain differences in the rewarding and dopamine-releasing effects of morphine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Effects of 6-OHDA lesions in the nucleus accumbens on the acquisition of self injection of heroin under schedule and non schedule conditions in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Effects of 6-OHDA lesions of the central medial nucleus accumbens on rat intravenous morphine self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900150-8

7 January 2021

10.1016/S0376-8716(01)00150-8

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11714590